Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD)
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Alzheimer's Disease
Related studies linked through entity extraction aliases.
18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians
- Status
- WITHDRAWN
- Phase
- NA
Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies
- Status
- RECRUITING
- Phase
- N/A
CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease
- Status
- COMPLETED
- Phase
- N/A
Blood-brain Barrier Leakage in Dementia. A Dynamic Contrast-enhanced MRI Study
- Status
- UNKNOWN
- Phase
- N/A
A Phase III Trial of Nilvadipine to Treat Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE3
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Alzheimer's Disease Biomarkers in Cerebrospinal Fluid in Insulin-resistant Men
- Status
- COMPLETED
- Phase
- N/A
Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With an Acetylcholinesterase Inhibitor
- Status
- COMPLETED
- Phase
- PHASE3
Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
- Status
- COMPLETED
- Phase
- PHASE3
Usability Study of Spaced Retrieval Exercise Using Mobile Devices for Alzheimer's Disease Rehabilitation
- Status
- COMPLETED
- Phase
- N/A
Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025
- Status
- TERMINATED
- Phase
- PHASE3
Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability
- Status
- COMPLETED
- Phase
- PHASE2
Alzheimer's Prevention Through Exercise
- Status
- COMPLETED
- Phase
- NA
A Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer's Disease (AD), Including a Placebo-Treated Non-Carrier Cohort
- Status
- COMPLETED
- Phase
- PHASE2
Impact of a Memory Group for Older Adults Reporting Memory Difficulties
- Status
- COMPLETED
- Phase
- NA
Construction-LBD (Constructional Apraxia in Alzheimer's Disease (AD) and Lewy Body's Dementia (LBD))
- Status
- UNKNOWN
- Phase
- NA
A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Genistein as a Possible Treatment for Alzheimer's Disease.
- Status
- COMPLETED
- Phase
- NA